X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (4) 4
abridged index medicus (2) 2
antibodies, monoclonal - administration & dosage (2) 2
atorvastatin calcium (2) 2
cardiac & cardiovascular systems (2) 2
cardiology and cardiovascular medicine (2) 2
cholesterol (2) 2
double-blind method (2) 2
female (2) 2
heptanoic acids - administration & dosage (2) 2
humans (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (2) 2
hypercholesterolemia (2) 2
index medicus (2) 2
lipids (2) 2
lipoprotein a (2) 2
low density lipoproteins (2) 2
male (2) 2
middle aged (2) 2
monoclonal antibodies (2) 2
pcsk9 (2) 2
pyrroles - administration & dosage (2) 2
safety (2) 2
time factors (2) 2
treatment outcome (2) 2
14 randomized-trials (1) 1
adult (1) 1
aged (1) 1
analysis (1) 1
antibodies (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal - therapeutic use (1) 1
anticholesteremic agents (1) 1
anticholesteremic agents - administration & dosage (1) 1
anticholesteremic agents - adverse effects (1) 1
anticholesteremic agents - therapeutic use (1) 1
antilipemic agents (1) 1
apolipoprotein-b (1) 1
atherosclerosis (1) 1
atorvastatin (1) 1
cardiovascular agents (1) 1
cardiovascular disease (1) 1
cardiovascular outcomes (1) 1
cardiovascular risk (1) 1
care and treatment (1) 1
catabolism (1) 1
cholesterol, ldl - blood (1) 1
cholic acids - blood (1) 1
clinical medicine (1) 1
clinical trials (1) 1
complications and side effects (1) 1
cutaneous vasculitis (1) 1
diabetes (1) 1
disease (1) 1
dose-response relationship, drug (1) 1
drug administration schedule (1) 1
drug synergism (1) 1
drug therapy, combination (1) 1
efficacy (1) 1
familial hypercholesterolemia (1) 1
follow-up studies (1) 1
hypercholesterolemia - blood (1) 1
hypercholesterolemia - drug therapy (1) 1
influenza (1) 1
inhibition (1) 1
internal medicine (1) 1
laboratories (1) 1
lipoprotein - blood (1) 1
lipoproteins (1) 1
low density lipoprotein (1) 1
low-density lipoprotein cholesterol (1) 1
low-density-lipoprotein (1) 1
metaanalysis (1) 1
mutation (1) 1
nephelometry and turbidimetry (1) 1
pain (1) 1
patient safety (1) 1
population (1) 1
prevention (1) 1
product development (1) 1
proprotein convertase 9 (1) 1
proprotein convertases - antagonists & inhibitors (1) 1
proprotein convertases - metabolism (1) 1
proteases (1) 1
reduction (1) 1
regression analysis (1) 1
sar236553/regn727 (1) 1
serine (1) 1
serine endopeptidases - metabolism (1) 1
statin (1) 1
statins (1) 1
steroid metabolism, inborn errors - blood (1) 1
steroid metabolism, inborn errors - drug therapy (1) 1
studies (1) 1
subtilisin - immunology (1) 1
therapy (1) 1
thrombin (1) 1
triglycerides (1) 1
universities and colleges (1) 1
viral antibodies (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 25, pp. 2344 - 2353
Objectives The primary objective of this study was to evaluate the low-density lipoprotein cholesterol (LDL-C)–lowering efficacy of 5 SAR236553/REGN727... 
Cardiovascular | Internal Medicine | statin | low-density lipoprotein cholesterol | safety | apolipoprotein-B | PCSK9 | SAR236553/REGN727 | hypercholesterolemia | CUTANEOUS VASCULITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CHOLESTEROL | CARDIOVASCULAR OUTCOMES | LOW-DENSITY-LIPOPROTEIN | PREVENTION | REDUCTION | DISEASE | 14 RANDOMIZED-TRIALS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Time Factors | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - blood | Double-Blind Method | Proprotein Convertases - metabolism | Treatment Outcome | Anticholesteremic Agents - adverse effects | Drug Synergism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Aged | Serine Endopeptidases - metabolism | Proprotein Convertase 9 | Care and treatment | Serine | Low density lipoproteins | Antibodies | Thrombin | Lipoprotein A | Cholesterol | Cardiovascular agents | Antilipemic agents | Viral antibodies | Complications and side effects | Hypercholesterolemia | Proteases | Monoclonal antibodies | Universities and colleges | Laboratories | Lipids | Triglycerides | Lipoproteins | Pain | Influenza | Patient safety | Population | Mutation | Clinical medicine | Diabetes | Statins | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 114, Issue 5, pp. 711 - 715
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.